ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
David R. Clarke
Mark F. O’Brien
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, S.
Right arrow Articles by O’Brien, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, S.
Right arrow Articles by O’Brien, M. F.

Ann Thorac Surg 2000;70:1962-1969
© 2000 The Society of Thoracic Surgeons

Original article: cardiovascular

Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft

Steven Goldstein, PhDa, David R. Clarke, MDb, Steven P. Walsh, PhDa, Kirby S. Black, PhDa, Mark F. O’Brien, MDc

a CryoLife, Inc, Kennesaw, Georgia, USA
b University of Colorado Health Science Center, Denver, Colorado, USA
c Prince Charles Hospital, Brisbane, Australia

Address reprint requests to Dr Goldstein, CryoLife, Inc, 1655 Roberts Blvd, NW, Kennesaw, GA 30144
e-mail: goldstein.steven{at}cryolife.com

Presented at the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. Tissue engineering approaches utilizing biomechanically suitable cell-conductive matrixes should extend xenograft heart valve performance, durability, and growth potential to an extent presently attained only by the pulmonary autograft. To test this hypothesis, we developed an acellular, unfixed porcine aortic valve-based construct. The performance of this valve has been evaluated in vitro under simulated aortic conditions, as a pulmonary valve replacement in sheep, and in aortic and pulmonary valve replacement in humans.

Methods. SynerGraft porcine heart valves (CryoLife Inc, Kennesaw, GA) were constructed from porcine noncoronary aortic valve cusp units consisting of aorta, noncoronary aortic leaflet, and attached anterior mitral leaflet (AML). After treatment to remove all histologically demonstrable leaflet cells and substantially reduce porcine cell-related immunoreactivity, three valve cusps were matched and sewn to form a symmetrical root utilizing the AML remnants as the inflow conduit. SynerGraft valves were evaluated by in vitro hydrodynamics, and by in vivo implants in the right ventricular outflow tract of weanling sheep for up to 336 days. Cryopreserved allograft valves served as control valves in both in vitro and in vivo evaluations. Valves were also implanted as aortic valve replacements in humans.

Results. In vitro pulsatile flow testing of the SynerGraft porcine valves demonstrated excellent valve function with large effective orifice areas and low gradients equivalent to a normal human aortic valve. Implants in sheep right ventricular outflow tracts showed stable leaflets with up to 80% of matrix recellularization with host fibroblasts and/or myofibroblasts, and with no leaflet calcification over 150 days, and minimal deposition at 336 days. Echocardiography studies showed normal hemodynamic performance during the implantation period. The human implants have proven functional for over 9 months.

Conclusions. A unique heart valve construct has been engineered to achieve the equivalent of an autograft. Short-term durability of these novel implants demonstrates for the first time the possibility of an engineered autograft.




This article has been cited by other articles:


Home page
 ICVTSHome page
G. Van Nooten, P. Somers, M. Cornelissen, S. Bouchez, F. Gasthuys, E. Cox, L. Sparks, and K. Narine
Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV(R) valves in the sheep model
Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 544 - 549.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Lichtenberg, I. Tudorache, S. Cebotari, M. Suprunov, G. Tudorache, H. Goerler, J.-K. Park, D. Hilfiker-Kleiner, S. Ringes-Lichtenberg, M. Karck, et al.
Preclinical Testing of Tissue-Engineered Heart Valves Re-Endothelialized Under Simulated Physiological Conditions
Circulation, July 4, 2006; 114(1_suppl): I-559 - I-565.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
U.A. Stock, I. Degenkolbe, T. Attmann, K. Schenke-Layland, S. Freitag, and G. Lutter
Prevention of device-related tissue damage during percutaneous deployment of tissue-engineered heart valves
J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1323 - 1330.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
I. Vesely
Heart Valve Tissue Engineering
Circ. Res., October 14, 2005; 97(8): 743 - 755.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. J. Zehr, M. Yagubyan, H. M. Connolly, S. M. Nelson, and H. V. Schaff
Aortic root replacement with a novel decellularized cryopreserved aortic homograft: Postoperative immunoreactivity and early results
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1010 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
V. J. Nina, P. M. Pomerantzeff, I. S. Casagrande, D. T Cheung, C. M. Brandao, and S. A Oliveira
Comparative Study of the L-Hydro Process and Glutaraldehyde Preservation
Asian Cardiovasc Thorac Ann, September 1, 2005; 13(3): 203 - 207.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. R. Meyer, J. Nagendran, L. S. Desai, G. R. Rayat, T. A. Churchill, C. C. Anderson, R. V. Rajotte, J. R.T. Lakey, and D. B. Ross
Decellularization reduces the immune response to aortic valve allografts in the rat
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 469 - 476.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Sayk, I. Bos, U. Schubert, T. Wedel, and H.-H. Sievers
Histopathologic Findings in a Novel Decellularized Pulmonary Homograft: An Autopsy Study
Ann. Thorac. Surg., May 1, 2005; 79(5): 1755 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J.F. M. Bechtel, J. Gellissen, A. W. Erasmi, M. Petersen, A. Hiob, U. Stierle, and H.-H. Sievers
Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 410 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. Stamm, A. Khosravi, N. Grabow, K. Schmohl, N. Treckmann, A. Drechsel, M. Nan, K.-P. Schmitz, A. Haubold, and G. Steinhoff
Biomatrix/Polymer Composite Material for Heart Valve Tissue Engineering
Ann. Thorac. Surg., December 1, 2004; 78(6): 2084 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. R. Kanter, D. A. Fyfe, W. T. Mahle, J. M. Forbess, and P. M. Kirshbom
Results with the freestyle porcine aortic root for right ventricular outflow tract reconstruction in children
Ann. Thorac. Surg., December 1, 2003; 76(6): 1889 - 1895.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. W. Grauss, M. G. Hazekamp, S. van Vliet, A. C. Gittenberger-de Groot, and M. C. DeRuiter
Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2003 - 2010.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
W. Wells, M. Malas, C. J. Baker, S. M. Quardt, and M. L. Barr
Depopulated vena caval homograft: a new venous conduit
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
P. Simon, M.T. Kasimir, G. Seebacher, G. Weigel, R. Ullrich, U. Salzer-Muhar, E. Rieder, and E. Wolner
Early failure of the tissue engineered porcine heart valve SYNERGRAFTTM in pediatric patients
Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 1002 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. M. Nugent and E. R. Edelman
Tissue Engineering Therapy for Cardiovascular Disease
Circ. Res., May 30, 2003; 92(10): 1068 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Cebotari, H. Mertsching, K. Kallenbach, S. Kostin, O. Repin, A. Batrinac, C. Kleczka, A. Ciubotaru, and A. Haverich
Construction of Autologous Human Heart Valves Based on an Acellular Allograft Matrix
Circulation, September 24, 2002; 106(12_suppl_1): I-63 - I-68.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. R. Clarke
Presidential address: Value, viability, and valves
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 1 - 6.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
W. J. Wells, H. Arroyo Jr, R. M. Bremner, J. Wood, and V. A. Starnes
Homograft conduit failure in infants is not due to somatic outgrowth
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 88 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
D. R. Clarke, R. M. Lust, Y. S. Sun, K. S. Black, and J. D. Ollerenshaw
Transformation of nonvascular acellular tissue matrices into durable vascular conduits
Ann. Thorac. Surg., May 1, 2001; 71 (2007): S433 - S436.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.